BioCorRx Inc. (BICX)
OTCMKTS
· Delayed Price · Currency is USD
0.3110
0.00 (0.00%)
May 19, 2025, 4:00 PM EDT
BioCorRx Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 0.14 | 0.01 | 0.09 | 0.21 | 0.05 | 0.12 | Upgrade
|
| Revenue Growth (YoY) | 165.47% | -91.40% | -58.30% | 342.99% | -60.63% | -48.96% | Upgrade
|
| Cost of Revenue | - | 0 | 0.04 | 0.02 | 0.01 | 0.1 | Upgrade
|
| Gross Profit | 0.14 | 0.01 | 0.05 | 0.2 | 0.04 | 0.03 | Upgrade
|
| Selling, General & Admin | 3.75 | 3.61 | 2.88 | 3.41 | 3.74 | 3.17 | Upgrade
|
| Research & Development | 1.43 | 1.48 | 0.89 | 1.46 | 1.61 | 4.27 | Upgrade
|
| Operating Expenses | 5.23 | 5.13 | 3.79 | 4.9 | 5.41 | 7.52 | Upgrade
|
| Operating Income | -5.09 | -5.12 | -3.74 | -4.7 | -5.37 | -7.49 | Upgrade
|
| Interest Expense | -1.41 | -1.53 | -0.89 | -1.09 | -0.57 | -0.51 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.97 | 1.6 | 0.94 | 1.79 | 0.87 | 4.5 | Upgrade
|
| EBT Excluding Unusual Items | -4.53 | -5.05 | -3.69 | -4 | -5.07 | -3.51 | Upgrade
|
| Asset Writedown | - | - | -0.05 | - | -0.14 | - | Upgrade
|
| Legal Settlements | - | - | - | -0.32 | - | - | Upgrade
|
| Other Unusual Items | -0.3 | -0.16 | -0.03 | -0.06 | - | - | Upgrade
|
| Pretax Income | -4.83 | -5.21 | -3.77 | -4.38 | -5.21 | -3.51 | Upgrade
|
| Earnings From Continuing Operations | -4.83 | -5.21 | -3.77 | -4.38 | -5.21 | -3.51 | Upgrade
|
| Minority Interest in Earnings | 0.12 | 0.11 | 0 | 0.01 | 0 | 0.03 | Upgrade
|
| Net Income | -4.71 | -5.11 | -3.77 | -4.37 | -5.21 | -3.47 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 0.07 | - | Upgrade
|
| Net Income to Common | -4.71 | -5.11 | -3.77 | -4.37 | -5.28 | -3.47 | Upgrade
|
| Shares Outstanding (Basic) | 12 | 10 | 8 | 7 | 6 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 12 | 10 | 8 | 7 | 6 | 5 | Upgrade
|
| Shares Change (YoY) | 40.13% | 25.41% | 15.92% | 10.90% | 20.70% | 52.64% | Upgrade
|
| EPS (Basic) | -0.39 | -0.49 | -0.45 | -0.61 | -0.81 | -0.65 | Upgrade
|
| EPS (Diluted) | -0.40 | -0.49 | -0.45 | -0.61 | -0.81 | -0.65 | Upgrade
|
| Free Cash Flow | -1.45 | -1.1 | -1.85 | -2.04 | -3.54 | -2.16 | Upgrade
|
| Free Cash Flow Per Share | -0.12 | -0.10 | -0.22 | -0.28 | -0.55 | -0.40 | Upgrade
|
| Gross Margin | 100.00% | 78.25% | 59.64% | 92.86% | 87.82% | 21.75% | Upgrade
|
| Operating Margin | -3664.61% | -66829.81% | -4194.50% | -2196.96% | -11121.62% | -6109.86% | Upgrade
|
| Profit Margin | -3390.40% | -66616.10% | -4224.89% | -2043.30% | -10934.66% | -2831.68% | Upgrade
|
| Free Cash Flow Margin | -1040.86% | -14302.07% | -2078.60% | -954.81% | -7332.77% | -1762.42% | Upgrade
|
| EBITDA | -5.04 | -5.09 | -3.71 | -4.67 | -5.3 | -7.41 | Upgrade
|
| D&A For EBITDA | 0.05 | 0.03 | 0.03 | 0.03 | 0.06 | 0.08 | Upgrade
|
| EBIT | -5.09 | -5.12 | -3.74 | -4.7 | -5.37 | -7.49 | Upgrade
|
| Advertising Expenses | - | 0.03 | 0.11 | 0.33 | 0.43 | 0.44 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.